Albimus Tablet

Adult dose

Generally, 2 tablets are taken orally twice daily in the morning and before bedtime, regardless of meals. 1) Gastric and duodenal ulcers 2 tablets are taken orally twice daily or 4 tablets are taken once daily before bedtime. Particularly for duodenal ulcer patients, administering 4 tablets twice daily in the morning and before bedtime can yield a higher treatment success rate. For ulcers due to non-steroidal anti-inflammatory drug administration, the dosage remains the same for co-therapy in prevention of gastric and duodenal ulcers during long-term use of NSAIDs. Typically, diseases due to NSAID use heal within 8 weeks, but healing time may occasionally be extended depending on the patient. For recurrent ulcer patients who have shown excellent effects with short-term therapy of this medication, a maintenance therapy of 2 tablets once daily at bedtime is indicated. 2) Gastroesophageal reflux disease For 8 weeks, either 2 tablets taken twice daily or 4 tablets taken once daily at bedtime. However, for patients with severe gastroesophageal reflux disease, the dosage can be increased to 4 tablets four times a day. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets orally three times daily, and it can be increased as needed. In severe cases, under medical supervision, doses of up to 6 g of ranitidine per day may be administered. 4) Peptic ulcers, acute stress ulcers, and upper gastrointestinal bleeding due to acute mucosal lesions Once oral administration is possible, transition from injection to oral dosing with 2 tablets taken twice daily. 5) Pre-anesthetic dosing (preventing Mendelson's syndrome) Administer 2 tablets 2 hours prior to anesthesia induction. In this case, taking 2 tablets the night before surgery is also beneficial.

This medication should not be used in patients undergoing dialysis or those with poor kidney function. Additionally, it should not be administered to patients who have had an allergic reaction to this medication or its components, a history of acute porphyria, patients who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants or newborns, and patients on a restricted potassium diet. Patients with liver dysfunction, a history of drug hypersensitivity, the elderly, those with a history of renal impairment, and patients taking non-steroidal anti-inflammatory drugs should use this medication with caution. Particularly, it may mask symptoms of gastric cancer, so gastric ulcer patients or those over middle age with newly occurring dyspeptic symptoms should use it only after confirming the nature of the malignant condition. While taking this medication, allergy reactions, blood abnormalities, liver dysfunction, cardiac arrhythmias, gastrointestinal symptoms, and psychiatric symptoms may arise, so if any symptoms occur, immediate consultation with medical personnel is advised. Long-term use should be avoided, and it should be administered at the minimum effective dose while monitoring treatment progress. It is advisable to avoid driving or operating dangerous machinery if dizziness or drowsiness occurs. This medication may interact with other drugs; thus, it is important to inform healthcare providers, especially if taking anticoagulants, antibiotics, or anticonvulsants, to ensure proper caution. Pregnant or breastfeeding women are advised not to use this medication, and its safety and efficacy have not been confirmed in children, so it is best not to administer it to them. In cases of overdose, appropriate treatment such as vomiting or gastric lavage may be necessary, and in severe cases, removal via hemodialysis may be required. Finally, this medication can reduce gastric acid secretion and promote bacterial proliferation in the stomach; long-term users should undergo ophthalmic examinations.

Serious side effects

• Hives
• angioedema
• chest pain
• shock (anaphylactic shock)
• angioedema (a severe allergic reaction)
• jaundiced or non-jaundiced hepatitis
• liver dysfunction
• consciousness disorders
• seizures
• hepatic myoclonus

Mild side effects

• Skin rash
• hives
• angioedema
• fever
• hypotension
• chest pain
• elevated serum enzyme levels
• nausea
• vomiting
• constipation

This medication should be stored in a sealed container to prevent air exposure, ideally at a temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for a longer duration.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle